Forging India’s bioeconomy
Without the support of its government, the Indian biotech industry may not be able to achieve its high potential, say James…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Wake up call for Indian pharma
Unless Indian pharma companies wake up to the new “patent challenge” regime, they could “miss the bus”, opines Dr Gopakumar G…
DRL launches docetaxel injection in US
Docetaxel injection USP, 20 mg/mL and 80 mg/4 mL are available as a single doseDr Reddy’s Laboratories (DRL) has launched…
‘In increasingly crowded markets like India, a recognised and trusted corporate brand is critical’
After the hiving off of its proprietary pharmaceuticals business, about half of the new Abbott’s business is either direct to…
Aurobindo Pharma to buy Natrol for $132.5 million
Emerges as the highest and best bidder to acquire the California-based company
Aurobindo Pharma USA, Aurobindo Pharma’s 100 per…
Venus gets marketing authorisation for Meropenem
Meropenem is a last-resort drug of the carbapenem class of antibiotics which is used in intensive care units (ICUs) of hospitals
…
US FDA committee votes against Novartis’ multiple myeloma lead
FDA not bound to follow Committee's guidance its review of LBH589 NDA
Novartis announced that the US Food and Drug…
Glenmark receives final ANDA approval for Omeprazole DR capsules
It is a generic version of Prilosec by AstraZeneca
Glenmark Generics has been granted final approval for its abbreviated new…
India pharma companies well positioned for global growth
Failure to comply with the stringent quality requirements in developed markets is a key risk
Growth for Indian pharma companies…
Merck Serono launches web-based software for people with MS
The software is available in six additional countries
Merck Serono, the biopharmaceutical division of Merck, announced the…